The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection.

[1]  H. Verbrugh,et al.  Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. , 1995, The Journal of infectious diseases.

[2]  B. Doebbeling,et al.  Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage. , 1994, Archives of internal medicine.

[3]  I. Hudson,et al.  The efficacy of intranasal mupirocin in the prevention of staphylococcal infections: a review of recent experience. , 1994, The Journal of hospital infection.

[4]  M. Pérez-Fontán,et al.  Treatment of Staphylococcus aureus nasal carriers in continuous ambulatory peritoneal dialysis with mupirocin: long-term results. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  J. Patterson,et al.  An outbreak of mupirocin-resistant Staphylococcus aureus on a dermatology ward associated with an environmental reservoir. , 1993 .

[6]  W. Lye,et al.  Methicillin-resistant Staphylococcus aureus nasal carriage and infections in CAPD. , 1993, Kidney international.

[7]  J. Gilbart,et al.  High-level mupirocin resistance in Staphylococcus aureus: evidence for two distinct isoleucyl-tRNA synthetases , 1993, Antimicrobial Agents and Chemotherapy.

[8]  L. Herwaldt,et al.  Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients. , 1993, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  R. Wenzel,et al.  Preoperative antibiotic prophylaxis. , 1992, The New England journal of medicine.

[10]  C. Watanakunakorn,et al.  The efficacy of mupirocin ointment and chlorhexidine body scrubs in the eradication of nasal carriage of Staphylococcus aureus among patients undergoing long-term hemodialysis. , 1991, American journal of infection control.

[11]  B. Cookson,et al.  Mupirocin-resistant Staphylococcus aureus , 1987, The Lancet.

[12]  H. Pohle,et al.  Association between Staphylococcus aureus nasopharyngeal colonization and septicemia in patients infected with the human immunodeficiency virus. , 1992, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.

[13]  R. Hill,et al.  Minimal dose requirements for nasal mupirocin and its role in the control of epidemic MRSA. , 1991, The Journal of hospital infection.

[14]  J. Boelaert,et al.  The use of nasal mupirocin ointment to prevent Staphylococcus aureus bacteraemias in haemodialysis patients: an analysis of cost-effectiveness. , 1991, The Journal of hospital infection.

[15]  L. Nicolle,et al.  Efficacy of mupirocin nasal ointment in eradicating Staphylococcus aureus nasal carriage in chronic haemodialysis patients. , 1991, The Journal of hospital infection.

[16]  B. Doebbeling,et al.  Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. , 1991, Annals of internal medicine.

[17]  M. Vilardell,et al.  von Willebrand factor activity in primary and in scleroderma-associated Raynaud's phenomenon , 1990, The Lancet.

[18]  B. Cookson.  Mupirocin resistance in staphylococci. , 1990, The Journal of antimicrobial chemotherapy.

[19]  G. Coles,et al.  Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. , 1990, The New England journal of medicine.

[20]  H. Neu.  The use of mupirocin in controlling methicillin-resistant Staphylococcus aureus. , 1990, Infection control and hospital epidemiology.

[21]  D. Castle,et al.  STAPHYLOCOCCAL CARRIAGE AND HIV INFECTION , 1989, The Lancet.

[22]  V. Yu,et al.  Staphylococcus aureus nasal carriage in hemodialysis patients. Its role in infection and approaches to prophylaxis. , 1989, Archives of internal medicine.

[23]  Denilson Barbosa,et al.  Staphylococcus aureus skin carriage and development of peritonitis in patients on continuous ambulatory peritoneal dialysis. , 1989, Clinical nephrology.

[24]  S. Davies,et al.  Staphylococcus Aureus Nasal Carriage, Exit-Site Infection and Catheter Loss in Patients Treated with Continuous Ambulatory Peritoneal Dialysis (CAPD) , 1989, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[25]  P. Hoeprich.  Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak: Hill RLR, Duckworth GJ, Casewell MW: J. Antimicrob Chemother 22:377–384, 1988 , 1989 .

[26]  M. Schurgers,et al.  The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in haemodialysis patients. , 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[27]  R. Hill,et al.  Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak. , 1988, The Journal of antimicrobial chemotherapy.

[28]  M. Jacobson,et al.  Staphylococcus aureus bacteremia and recurrent staphylococcal infection in patients with acquired immunodeficiency syndrome and AIDS-related complex. , 1988, The American journal of medicine.

[29]  G. E. Smith,et al.  Staphylococcus aureus resistant to mupirocin. , 1988, The Journal of antimicrobial chemotherapy.

[30]  B. Cookson,et al.  MUPIROCIN-RESISTANT STAPHYLOCOCCUS AUREUS , 1987, The Lancet.

[31]  D. Allison,et al.  Guidelines for the control of epidemic methicillin-resistant Staphylococcus aureus. , 1987, The Journal of hospital infection.

[32]  V. Yu,et al.  Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. , 1986, The New England journal of medicine.

[33]  R. Hill,et al.  The carrier state: methicillin-resistant Staphylococcus aureus. , 1986, The Journal of antimicrobial chemotherapy.

[34]  R. Hill,et al.  Elimination of nasal carriage of Staphylococcus aureus with mupirocin ('pseudomonic acid')--a controlled trial. , 1986, The Journal of antimicrobial chemotherapy.

[35]  R. Hill,et al.  In-vitro activity of mupirocin ('pseudomonic acid') against clinical isolates of Staphylococcus aureus. , 1985, The Journal of antimicrobial chemotherapy.

[36]  R. Haley,et al.  Identifying patients at high risk of surgical wound infection. A simple multivariate index of patient susceptibility and wound contamination. , 1985, American journal of epidemiology.

[37]  D. Oreopoulos,et al.  Staph aureus peritonitis in patients on continuous ambulatory peritoneal dialysis. , 1984, Transactions - American Society for Artificial Internal Organs.

[38]  E. J. Young,et al.  Staphylococcal nasal carriage and subsequent infection in peritoneal dialysis patients. , 1982, JAMA.

[39]  E. Mortimer,et al.  Importance of the carrier state as a source of Staphylococcus aureus in wound sepsis , 1969, Journal of Hygiene.

[40]  R. Blowers,et al.  Sources of staphylococcal infection in surgical wound sepsis , 1963, Journal of Hygiene.

[41]  A. White.  INCREASED INFECTION RATES IN HEAVY NASAL CARRIERS OF COAGULASE-POSITIVE STAPHYLOCOCCI. , 1963, Antimicrobial agents and chemotherapy.

[42]  I. A. Porter,et al.  Staphylococcal Infection in a Surgical Ward , 1961 .

[43]  R. Williams,et al.  Nasal Disinfection in Prevention of Post-operative Staphylococcal Infection of Wounds , 1961, British medical journal.

[44]  J. Griffiths,et al.  Nasal Staphylococci and Sepsis in Hospital Patients , 1959, British medical journal.

[45]  H. J. Weinstein.  The relation between the nasal-staphylococcal-carrier state and the incidence of postoperative complications. , 1959, The New England journal of medicine.

[46]  L. Tulloch,et al.  Nasal Carriage in Staphylococcal Skin Infections , 1954, British medical journal.